Literature DB >> 26531030

Drug assessment in the Ebola virus disease epidemic in west Africa.

Yazdan Yazdanpanah1, Peter Horby2, Johan van Griensven3, France Mentre4, Vinh-Kim Nguyen5, Jean Marie Denis Malvy6, Jake Dunning2, Daouda Sissoko6, Jean-Francois Delfraissy7, Yves Levy7.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26531030      PMCID: PMC5856333          DOI: 10.1016/S1473-3099(15)00344-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

1.  Design considerations for AIDS trials.

Authors:  D P Byar; D A Schoenfeld; S B Green; D A Amato; R Davis; V De Gruttola; D M Finkelstein; C Gatsonis; R D Gelber; S Lagakos
Journal:  N Engl J Med       Date:  1990-11-08       Impact factor: 91.245

2.  Clinical presentation of patients with Ebola virus disease in Conakry, Guinea.

Authors:  Elhadj Ibrahima Bah; Marie-Claire Lamah; Tom Fletcher; Shevin T Jacob; David M Brett-Major; Amadou Alpha Sall; Nahoko Shindo; William A Fischer; Francois Lamontagne; Sow Mamadou Saliou; Daniel G Bausch; Barry Moumié; Tim Jagatic; Armand Sprecher; James V Lawler; Thierry Mayet; Frederique A Jacquerioz; María F Méndez Baggi; Constanza Vallenas; Christophe Clement; Simon Mardel; Ousmane Faye; Oumar Faye; Baré Soropogui; Nfaly Magassouba; Lamine Koivogui; Ruxandra Pinto; Robert A Fowler
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245

3.  Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Authors:  John S Schieffelin; Jeffrey G Shaffer; Augustine Goba; Michael Gbakie; Stephen K Gire; Andres Colubri; Rachel S G Sealfon; Lansana Kanneh; Alex Moigboi; Mambu Momoh; Mohammed Fullah; Lina M Moses; Bethany L Brown; Kristian G Andersen; Sarah Winnicki; Stephen F Schaffner; Daniel J Park; Nathan L Yozwiak; Pan-Pan Jiang; David Kargbo; Simbirie Jalloh; Mbalu Fonnie; Vandi Sinnah; Issa French; Alice Kovoma; Fatima K Kamara; Veronica Tucker; Edwin Konuwa; Josephine Sellu; Ibrahim Mustapha; Momoh Foday; Mohamed Yillah; Franklyn Kanneh; Sidiki Saffa; James L B Massally; Matt L Boisen; Luis M Branco; Mohamed A Vandi; Donald S Grant; Christian Happi; Sahr M Gevao; Thomas E Fletcher; Robert A Fowler; Daniel G Bausch; Pardis C Sabeti; S Humarr Khan; Robert F Garry
Journal:  N Engl J Med       Date:  2014-10-29       Impact factor: 91.245

4.  Evaluating clinical trial designs for investigational treatments of Ebola virus disease.

Authors:  Ben S Cooper; Maciej F Boni; Wirichada Pan-ngum; Nicholas P J Day; Peter W Horby; Piero Olliaro; Trudie Lang; Nicholas J White; Lisa J White; John Whitehead
Journal:  PLoS Med       Date:  2015-04-14       Impact factor: 11.069

Review 5.  Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

Authors:  Simone Lanini; Alimuddin Zumla; John P A Ioannidis; Antonino Di Caro; Sanjeev Krishna; Lawrence Gostin; Enrico Girardi; Michel Pletschette; Gino Strada; Aldo Baritussio; Gina Portella; Giovanni Apolone; Silvio Cavuto; Roberto Satolli; Peter Kremsner; Francesco Vairo; Giuseppe Ippolito
Journal:  Lancet Infect Dis       Date:  2015-04-14       Impact factor: 25.071

  5 in total
  3 in total

1.  A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

Authors:  Richard T Davey; Lori Dodd; Michael A Proschan; James Neaton; Jacquie Neuhaus Nordwall; Joseph S Koopmeiners; John Beigel; John Tierney; H Clifford Lane; Anthony S Fauci; Moses B F Massaquoi; Foday Sahr; Denis Malvy
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

Review 2.  Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 3.  A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines.

Authors:  Thomas Richardson; Andrew McDonald Johnston; Heather Draper
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.